Abstract:Background Chronic pain is an enormous economic and personal health burden worldwide, with more than one-third of the population suffering from chronic pain. However, no studies have systematically analyzed the potential role of plasma metabolites in chronic original pain. Methods Pooled genome-wide association study (GWAS) data for 1400 plasma metabolites from Brent Richards' research were used as exposures and genetic data from the UK Biobank related to 8 chronic regional pains were used as outcomes, including headache, facial pain, neck and shoulder pain, back pain, hip pain, abdominal pain, knee pain, and general pain. Causal associations between genetically predicted plasma metabolites and chronic regional pain were analyzed using the inverse variance weighting (IVW) method as the main tool for Mendelian randomization (MR) analyses, and horizontal pleiotropy tests and sensitivity analyses were performed for each pain phenotype by MR PRESSO and leave-one-out. In addition, four additional analyses were used to strengthen our findings, including weighted median, sample mode, weighted mode, and MR Egger. Finally, inverse MR analyses were performed to refine our results further. Results Significant evidence from MR analyses showed that 134 plasma metabolites associated with eight chronic pain conditions were screened for MR analysis, and a total of 140 associations showing evidence of causality were identified, with six metabolites acting in both pain conditions. Of these, 78 were identified as protective factors for chronic regional pain and 66 as risk factors. Notably, sensitivity analyses and heterogeneity tests strengthened the reliability of these results. The reverse MR analysis showed that neck-shoulder pain decreased the AMP to N-palmitoyl-sphingosine ratio. Conclusions The results of this research provide genetic proof for the study of chronic pain, revealing a latent genetic propensity between plasma metabolites and chronic pain, and identifying a role for plasma metabolites in different chronic pain phenotypes. These insights provide a framework for future clinical trials, suggesting that future research directions could focus on interventions related to plasma metabolites to treat or moderate chronic regional pain and its associated risk factors.

Causal Relationship Between Plasma Metabolites and Chronic Original Pain: a Mendelian Randomization Study